Carboprost Tromethamine Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 250 mcg/mL
Reference Brands: Hemabate® (EU & US)
Category:
Women's Health
Carboprost Tromethamine Injection (250 mcg/mL) is used to treat postpartum hemorrhage and for medical abortion in the second trimester. Known by the brand Hemabate®, it is FDA- and EMA-approved. Ideal for hospitals and OB/GYN units, this uterotonic is available from trusted GMP-certified suppliers across the US and EU for reliable, emergency maternal care solutions.
Carboprost Tromethamine is available in Injection
and strengths such as 250 mcg/mL.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Carboprost Tromethamine is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Carboprost Tromethamine can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Carboprost Tromethamine Injection is a synthetic prostaglandin analogue used for the treatment of postpartum hemorrhage due to uterine atony and for second-trimester abortion. Trusted in hospitals and maternity care across the US and EU, it is marketed under brand names like Hemabate® (Pfizer). Typically available as 250 mcg/mL in 1 mL ampoules or vials, it is administered intramuscularly under clinical supervision. Approved by the FDA and EMA, Carboprost is a critical uterotonic agent in obstetric emergencies. B2B pharmaceutical distributors and healthcare facilities rely on GMP-certified sources to ensure timely access to high-quality Carboprost for maternal health protocols.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing